[oncoMASTER Director's press release] "Targeted treatment for lung cancer that has emerged up to the third generation, effective against resistance and brain metastasis" (July 20, 2022, Magazine Environment)

“Targeted treatments for lung cancer that have emerged up to the third generation are effective against resistance and brain metastasis.”

[Interview] Kim Yeol-hong, Professor at Korea University

Recraza insurance applies from July 2021… Overall survival time of 38.9 months is encouraging.

link

https://magazine.hankyung.com/business/article/202207135838b

Source: Magazine Environment (Reporters Kim Young-eun, Seo Beom-se_2022. 07. 20)